Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements (Goldilocks)
Goldilocks' Zone: Optimised Osmolality in Supplements for the Patient With an Ileostomy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus C, Denmark, 8000
- Department of medicine V (Hepatology and Gastroenterology)
-
Aarhus N, Denmark, 8200
- Aarhus University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 18 years or higher
- ileostomy formed at least 8 weeks before enrolment
- consent to participate
Exclusion Criteria:
- pregnancy
- known chronic kidney disease
- known diabetes mellitus
- too long driving distance
- parenteral nutrition/fluid more than 6 litres per month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: hypoosmolar
One with a hypo-osmolar fluid
|
oral commercially available supplements
|
|
Active Comparator: isoosmolar
one with an iso-osmolar fluid
|
oral commercially available supplements
|
|
Active Comparator: hyperosmolar
one with a hyper-osmolar
|
oral commercially available supplements
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ileostomy output
Time Frame: 6 hours
|
ileostomy output (wet weight feces grams)
|
6 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
natriuresis
Time Frame: 6 hours
|
urine volume (mL)
|
6 hours
|
|
urine sodium
Time Frame: 6 hours
|
urine sodium mmol
|
6 hours
|
|
urine osmolality
Time Frame: 6 hours
|
urine osmolality (mmol/kg)
|
6 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Intestinal Diseases
- Digestive System Diseases
- Gastrointestinal Diseases
- Water-Electrolyte Imbalance
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Intestinal Failure
- Dehydration
- Therapeutics
- Diet, Food, and Nutrition
- Physiological Phenomena
- Nutritional Physiological Phenomena
- Inorganic Chemicals
- Diet Therapy
- Nutrition Therapy
- Diet
- Anions
- Ions
- Electrolytes
- Hydroxides
- Alkalies
- Oxides
- Oxygen Compounds
- Water
- Diet, Fat-Restricted
Other Study ID Numbers
Other Study ID Numbers
- 1-10-72-289-21
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.